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Background. Data on community spread of methicillin-resistant coagulase-negative staphylococci (MR-CoNS)
are scarce. We assessed their potential role as a reservoir of staphylococcal cassette chromosome mec (SCCmec)
IVa, the leading SCCmec subtype in community-acquired methicillin-resistant Staphylococcus aureus (CA-MRSA).
Methods. Nasal carriage of MR-CoNS was prospectively investigated in 291 adults at hospital admission. MR-
CoNS were characterized by SCCmec typing, long-range polymerase chain reaction (PCR) for SCCmec IV, and
multiple-locus variable-number tandem repeat analysis (MLVA) for Staphylococcus epidermidis (MRSE) strains.
Three SCCmec IVa elements were fully sequenced.
Results. The carriage rate of MR-CoNS was 19.2% (25.9% and 16.5% in patients with and patients without
previous exposure to the health care system, respectively; Pp .09). MR-CoNS strains (np83, including 58 MRSE
strains with highly heterogeneous MLVA patterns) carried SCCmec type IVa (np9, all MRSE), other SCCmec IV
subtypes (np9, including 7 MRSE), other SCCmec types (np15), and nontypeable SCCmec (np50). Long-
range PCR indicated structural homology between SCCmec IV in MRSE and that in MRSA. Complete sequences
of SCCmec IVa from 3 MRSE strains were highly homologous to those available for CA-MRSA, including major
clones USA300 and USA400.
Conclusions. MR-CoNS are probably disseminated in the community, notably in subjects without previous
exposure to the health care system. MRSE, the most prevalent species, may act as a reservoir of SCCmec IVa for
CA-MRSA.
Methicillin-resistant Staphylococcus aureus (MRSA) has
been almost exclusively a health care–associated path-
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ogen until the nineties. Community-acquired strains
(CA-MRSA) have now emerged worldwide and are in-
creasingly reported in a wide spectrum of diseases,
ranging from moderate skin infections to severe nec-
rotizing pneumonia, most often in patients with no
comorbidities or risk factors [1, 2]. A few CA-MRSA
clones appear highly successful in terms of geographic
dissemination, for example, sequence type (ST) 80 from
Europe, USA300 (ST8) and USA400 (ST1) from North
America, and ST30 from Oceania, with evidence of
overseas spread and in-hospital diffusion [3–5]. New
CA-MRSA strains are frequently described and may
emerge continuously [4, 6–10].
The acquisition of methicillin resistance in staphy-
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lococci results from the recombinase-mediated insertion of
staphylococcal cassette chromosome mec (SCCmec), the mo-
bile genetic element carrying mecA, at the 3’ end of a chro-
mosomal open reading frame designated as orfX. Eight major
SCCmec types (I-VIII) are described in MRSA, differing in size
and in the allotypic combination of the mec (A, B, C) and the
recombinase-encoding ccr (types 1–4, ie, ccrAB1 to ccrAB4, and
type 5, ie, ccrC) gene complexes [9–14]. Major CA-MRSA
clones (including USA300, USA400, and ST80) harbor SCCmec
IVa, a subtype that is also currently diffusing among health
care–associated MRSA (HCA-MRSA) strains [15–19]. SCCmec
displays more polymorphous structure in methicillin-resistant
coagulase-negative staphylococci (MR-CoNS), with frequent
ccr-mec combinations not described in MRSA, and multiple
and/or untypeable ccr allotypes [20–22]. Non-mecA SCC ele-
ments have even been reported in Staphylococcus haemolyticus
and Staphylococcus epidermidis, possibly associated with argi-
nine catabolic mobile elements (ACME) in the latter species
[15, 23, 24]. Interestingly, recent data from Japan show that
SCCmec IVa also predominates among community-acquired
methicillin-resistant S. epidermidis (CA-MRSE) [25].
Several reports involving health care–associated strains sug-
gest that SCCmec transfer from MR-CoNS to methicillin-sus-
ceptible S. aureus (MSSA) may occur, although its mechanism
remains unknown [9, 22, 26–29]. MR-CoNS may thus act as
a source of SCCmec for MRSA. The frequency of methicillin
resistance in health care–associated CoNS is currently 160%
[30]. On the other hand, little is known about the prevalence
of methicillin resistance, the SCCmec diversity, and the res-
ervoir of SCCmec IVa among carriage strains of CoNS, notably
CA-MRSE, in western populations. Furthermore, no complete
sequence of SCCmec IVa from CA-MRSE has been published
so far, and homology with that carried by CA-MRSA could not
be estimated. In this work, nasal carriage of MR-CoNS was
prospectively studied in French adults at hospital admission.
SCCmec IVa was found to be disseminated in MRSE strains,
including from patients not previously exposed to the health
care system, and was highly homologous to that sequenced in
CA-MRSA.
STUDY POPULATION AND METHODS
Study population. All patients admitted to the orthopedic
surgery ward of the Bichat–Claude Bernard teaching hospital
(Paris, France) between 15 June and 16 September 2005 were
prospectively enrolled and classified by means of a standard-
ized questionnaire as previously exposed to the health care
system (EHCS) or unexposed (non-EHCS) (Table 1). Patients
were informed that these data may be analyzed for scien-
tific purposes.
Isolation of staphylococci isolates from nasal swab samples.
Within 6 h after ward admission, samples were obtained from
both nares with a single dry-cotton swab (Copan), and directly
inoculated onto Chapman (Oxoid) and MRSA Select (Bio-Rad)
agar. CoNS and S. aureus were identified by conventional meth-
ods after incubation for 48 h at 37C. For each subject, 2 MR-
CoNS isolates were randomly collected from the MRSA Select
agar, and 1 S. aureus strain, if present, was collected from the
Chapman agar. Carriage of MS-CoNS was not investigated. The
2 MR-CoNS isolates from each patient were further considered
duplicates of a single strain if they belonged to the same species
and displayed identical antibiotic resistance, SCCmec types, and
multiple-locus variable-number tandem repeat analysis (MLVA)
patterns for S. epidermidis isolates (see “Molecular character-
ization of MR-CoNS isolates,” below). Susceptibility to anti-
biotics (Table 2) was determined by disk diffusion (Bio-Rad)
according to French Society for Microbiology guidelines [31].
Molecular characterization of MR-CoNS isolates. DNA
was extracted with a MagNA Pure LC instrument (Roche).
mecA carriage was first confirmed by multiplex real-time poly-
merase chain reaction (PCR) analysis [32]. Isolates were iden-
tified by (1) comparison of an internal 1350-bp fragment of
the 16S ribosomal RNA gene with sequences available in the
National Center for Biotechnology Information databases, us-
ing the BLAST (Basic Local Alignment Search Tool) algorithm
(http://www.ncbi.nlm.nih.gov/blast) [33]; and (2) mass spec-
trometry (MALDI-TOF MS microflex LT, Bruker). MRSE iso-
lates were typed by MLVA, a method that assesses the length
polymorphism of 5 chromosomal variable-number tandem re-
peats designated as Se1–5 [34]. The diversity of MLVA patterns
was analyzed with BioNumerics software (version 6.0; Applied
Maths).
SCCmec was typed as described by Kondo et al [35] and
designated as type I/1B (ie, ccrAB1–class B mec), II/2A, III/3A,
IV/2B, V/5C2, VI/4B, or VIII/4A, according to the current no-
menclature used for MRSA [11]. MRSA strains COL/SCCmec
I, BK2464/II, ANS46c/III, USA300-FPR3757/IV(a), WCH100/
V, and HDE288/VI were used as references. SCCmec IV was
subtyped as IVa, IVb, IVc, IVd, and nonsubtypeable (IVnst) by
multiplex PCR [35]. Nontypeable SCCmec was defined by the
absence of typeable ccr allotypes or an undescribed ccr-mec
combination.
Structural analysis of SCCmec IV by long-range PCR. Type
IV SCCmec was compared by long-range PCR (LR-PCR) with
that described in MRSA in terms of orientation and sizes of
the junkyard regions J1 (from ccrB2 toward the 3’ right-flanking
chromosomal region), J2 (between mecA and ccrA2), and J3
(between orfX and mecA). Primers and reference SCCmec se-
quences are listed in Table 3. All LR-PCR were performed by
using the GeneAmp XL PCR Kit (Applied Biosystems), with
an initial denaturation step (94C for 4 min), 10 cycles of
denaturation (94C for 15 s), annealing (55C for 30 s), and
extension (68C for 7 min), followed by 25 cycles of denatur-
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Table 1. Nasal Carriage of Methicillin-Resistant Coagulase-Negative Staphylococci (MR-CoNS) and
Staphylococcus aureus in 291 Adults at Hospital Admission
Patient characteristic All patients
Health care system
PExposed Unexposed
All patients 291 85 (29.2) 206 (70.8)
Age, median years (range) 46 (15–103) 58 (15–103) 42 (16–92) !.001
Female sex 116 (39.9) 43 (50.6) 73 (35.4) .02
Exposure categories
Hospitalization during previous year … 72 (84.7) …
Life in a nursing home … 6 (7.1) …
Health care worker … 4 (4.7) …
Home nursing care … 2 (2.4) …
Long-term hemodialysis … 1 (1.2) …
Origina !.001
Emergency department 166 (57.0) 34 (40.0) 132 (64.1)
Home 125 (43.0) 51 (60.0) 74 (35.9)
Reason for hospitalizationa !.001
Urgent surgery 171 (58.8) 35 (41.2) 136 (66.0)
Trauma with bone fracture 95 (32.6) 25 (29.3) 70 (34.0)
Trauma without bone fractureb 64 (22.0) 7 (8.2) 57 (27.7)
Nontraumatic SSTI 8 (2.7) 1 (1.2) 7 (3.4)
Miscellaneous 4 (1.4) 2 (2.4) 2 (1.0)
Scheduled hospitalization 120 (41.2) 50 (58.9) 70 (34.0)
Primary surgical intervention 95 (32.7) 30 (35.3) 65 (31.6)
Surgical reintervention 14 (4.8) 14 (16.5) 0 (0)
Miscellaneous 11 (3.8) 6 (7.1) 5 (2.4)
Nasal colonization by MR-CoNS, overall 56 (19.2) 22 (25.9) 34 (16.5) .09
Nasal colonization by MRSE-SCCmec type IV 15 (5.2) 6 (7.1) 9 (4.4) .51
Nasal colonization by S. aureus, overall 48 (16.5) 14 (16.5) 34 (16.5) .87
MSSA 42 (14.4) 9 (10.6) 33 (16.0) .3
MRSA 6 (2.1) 5 (5.9) 1 (0.5) .01
Cocolonization by MSSA and MRSE-SCCmec type IVa 1 (0.3) 0 1 (0.5)
NOTE. Data are no. (%) of patients, unless otherwise indicated. MRSA, methicillin-resistant S. aureus; MRSE–SCCmec type
IV, methicillin-resistant Staphylococcus epidermidis carrying staphylococcal cassette chromosome mec type IV;MSSA,methicillin-
susceptible S. aureus; SSTI, skin and soft-tissue infection.
a Five patients requiring urgent surgery were directly hospitalized on their general practitioner’s request, without visiting the
emergency room.
b Including deep wounds, severe sprains, and joint dislocation.
ation (94C for 15 s), annealing (55C for 30 s), and extension
(68C for 7–10 min, with a 7-s increment per cycle), and a
final extension step (68C for 10 min). Amplicons were ana-
lyzed after migration in 1% agar in TAE buffer 0.5, us-
ing SYBR Safe gel stain (Invitrogen) as a double-strand DNA
marker, and 1Kb Plus DNA Size Ladder (Invitrogen).
Complete sequencing of 3 SCCmec IVa. SCCmec IVa and
surrounding chromosomal regions were sequenced in 3 ran-
domly selected MRSE strains from contiguous fragments cor-
responding to (1) the 3 LR-PCR amplicons described above
and overlapping the 3 junkyard regions; (2) the internal region
of mecA, sequenced after conventional PCR; and (3) an ad-
ditional LR-PCR amplicon for the junction between J1 and
SE0130, the chromosomal coding sequence (CDS) located im-
mediately downstream of orfX in S. epidermidis [24] (Table 3).
LR-PCR amplicons were sequenced with a GA-II Genome An-
alyzer (Illumina). A total of 857996, 1162881, and 896106 of
76 bases readings were obtained for strains BCB-F1, BCB-F57,
and BCB-F63, respectively (see Results). Readings were assem-
bled by using a combination of de novo and comparative as-
sembling approaches.
The reference sequence (indicated as strain/GenBank acces-
sion number/5′–3′ nucleotides position) used for comparative
assembly was USA300-FPR3757/CP000255/34189–56277. The
software applications used were Edena, version 2.1.1 [36];
MAQ, version 0.7.1 [37]; and Minimus2, which is part of the
AMOS package, version 2.0.8 [38]. Vector NTI software (In-
vitrogen) was used for alignment and comparison with refer-
ence sequences of orfX (MRSE RP62A/CP000029/2584176–
2584655, methicillin-susceptible S. epidermidis [MSSE] Amer-
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Table 2. Antibiotic Resistance Patterns of 83 Carriage Strains
of Methicillin-Resistant Coagulase-Negative Staphylococci (MR-
CoNS)
Antibiotic
resistance
MR-CoNS strains, no. (%)
P
Total
(n p 83)
EHCS subjects
(n p 32)
Non-EHCS
subjects
(n p 51)
Oxacillin 83 (100) 32 (100) 51 (100)
Kanamycin 47 (56.6) 25 (78.1) 22 (43.1) .004
Tobramycin 45 (54.2) 24 (75.0) 21 (41.2) .005
Gentamicin 28 (33.7) 11 (34.3) 17 (33.3) .88
Tetracycline 21 (25.3) 7 (21.9) 14 (27.4) .76
Rifampicin 8 (9.6) 5 (15.6) 3 (5.9) .28
Fosfomycin 24 (28.9) 9 (28.1) 15 (29.4) .90
Fusidic acid 33 (39.8) 13 (40.6) 20 (39.2) .92
Erythromycin 63 (75.9) 28 (87.5) 35 (68.6) .09
Lincomycin 18 (21.7) 10 (31.2) 8 (15.7) .16
Pristinamycin 1 (1.2) 1 (3.1) 0 …
Ofloxacin 28 (33.7) 16 (50.0) 12 (23.5) .02
Cotrimoxazole 20 (24.1) 9 (28.1) 11 (21.6) .68
Vancomycin 0 0 0 …
NOTE. Antibiotic susceptibility/resistance was determined by the disk dif-
fusion method, according to the French Society for Microbiology guidelines
[31]. EHCS, exposed to health care system.
ican Type Culture Collection [ATCC] 12228/AE015929/32031–
32510, CA-MRSA USA300-FPR3757CP000255/33711–34191,
CA-MRSA USA400-MW2/BA000033/33688–34168), SCCmec
IVa (CA-MRSA USA300-FPR3757/CP000255/34189–56277,
CA-MRSA USA400-MW2/BA000033/34145–57500, CA-
MRSA CA05-JCSC1968/AB063172/976–25205), SE0130 (MRSE
RP62A/CP000029/2491223–2492038, and MSSE ATCC 12228/
AE015929/126025–126840) [14–16, 24, 39]. All divergences
from reference sequences (ie, nucleotidic substitutions, inser-
tions, and deletions) were controlled for with specifically de-
signed primers.
Statistical analysis. The x2 test and analysis of variance
were used to compare nominal and continuous variables, re-
spectively. Differences were considered significant at P! .05.
RESULTS
Carriage rates of MR-CoNS and S. aureus. A total of 291
consecutive patients were enrolled in the study, including 85
EHCS patients (29.2%) and 206 non-EHCS patients (70.8%)
(Table 1). Compared with non-EHCS subjects, EHCS patients
were older (median age, 58 vs 42 years; P! .001) and were more
likely to have been admitted directly from home (60% vs 35.9%;
P! .001) for scheduled surgery (58.9% vs 34%; P! .001). The
overall prevalence of MR-CoNS carriage was 19.2% (np56).
Carriage rates in EHCS and non-EHCS subjects were 25.9%
and 16.5%, respectively (Pp .09). Forty-eight patients (16.5%)
carried S. aureus, including 6 with MRSA, with no MRSA or
MR-CoNS cocolonization.
MR-CoNS strains. Isolates (np112) were duplicates of a
single strain in 29 patients and represented 2 distinct strains
in the other 27 patients, including 16 with strains from different
species. The remaining 83 nonduplicate MR-CoNS strains in-
cluded in the analysis were identified as S. epidermidis (58
strains [69.9%]), Staphylococcus hominis (11 strains [13.3%]),
S. haemolyticus (10 strains [12.0%]), Staphylococcus pettenkoferi
(3 strains [3.6%]) (a recently described species [40]), and Staph-
ylococcus cohnii (1 strain [1.2%]). Only resistances to kana-
mycin, tobramycin, and ofloxacin were significantly more fre-
quent in MR-CoNS strains from EHCS than from non-EHCS
subjects (Table 2).
Type IV was the most frequent SCCmec variant (21.7%, see
below) (Table 4). SCCmec II and V were identified in 3 S.
epidermidis and 5 S. haemolyticus strains, respectively. Seven
strains (including 4 MRSE) carried a 4A combination, desig-
nated in MRSA as SCCmec VIII [9, 11]. Fifty strains (60.2%)
harbored nontypeable SCCmec, with 19 distinct patterns, in-
cluding double and triple ccr allotypes for 23 (27.7%) and 3
(3.6%) strains, respectively. Distribution of SCCmec types did
not differ significantly between MR-CoNS from EHCS and
non-EHCS patients.
Nasal colonization by MR-CoNS strains carrying SCCmec
type IV. Seventeen patients (5.8%) were colonized by MR-
CoNS strains (np18) carrying SCCmec type IV (9.4% in
EHCS vs 4.4% in non-EHCS subjects; not significant). Sixteen
strains (88.8%) were identified as S. epidermidis, with a cor-
responding carriage rate for MRSE-SCCmec IV of 5.2% (7.1%
in EHCS vs 4.4% in non-EHCS patients; not significant), and
2 were identified as S. pettenkoferi. One subject carried 2 distinct
strains of MRSE-SCCmec IV, and 6 were cocolonized by 1 strain
with SCCmec IV (4 S. epidermidis and 2 S. pettenkoferi) plus
another strain harboring a non–type IV SCCmec. One non-
EHCS subject carried MSSA as well as CA-MRSE with SCCmec
IVa.
MLVA typing of MRSE strains. Fifty-five (94.8%) of the
58 distinct MRSE strains were typeable by MLVA, with 3 of
the 5 targeted loci not amplifiable in the remaining 3 strains.
These 55 strains showed heterogeneous MLVA profiles, regard-
less of their origin (EHCS or non-EHCS patients) or their
SCCmec types (notably type IV), with no patent clonality (Fig-
ure 1).
Characterization of SCCmec type IV. SCCmec IVa was the
most frequent subtype (np9) among MRSE-SCCmec IV, fol-
lowed by IVnst (np6) and IVb (np1) (Table 4). S. petten-
koferi strains carried subtypes IVc and IVd.
LR-PCR indicated a marked structural homology of SCCmec
IV from MRSE with that described in MRSA. Insertion of
SCCmec at the 3′-end of orfX was confirmed in all strains, with
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Table 3. Primers Used for Long-Range Polymerase Chain Reaction Amplification of Staphylococcal Cassette Chromosome mec (SCCmec)
Type IV and Additional Primers Used for Complete Sequencing of SCCmec Subtype IVa
Primers and corresponding regions
Constructed
on 5′–3′ Sequence
Reference SCCmec
Straina
Start position,
nucleotide Length, bp
From orfX to mec (overlapping J3)
orfX-U2Rb orfX GTCAAAGAAAAAGAAGGCCAACG FPR3757 (IVa)
JCSC1978 (IVb)
MR108 (IVc)
33877
21516
30864
6213 (IVa)
6830 (IVb)
9481 (IVc)
mA1c mecA TGCTATCCACCCTCAAACAGG FPR3757 (IVa)
JCSC1978 (IVb)
MR108 (IVc)
40090
14686
21383
6213 (IVa)
6830 (IVb)
9481 (IVc)
From mec to ccrA2 (overlapping
J2)c
mA7 mecA ATATACCAAACCCGACAACTACA FPR3757 (IVa)
JCSC1978 (IVb)
MR108 (IVc)
41073
13703
20400
6904 (IVa)
6904 (IVb)
6905 (IVc)
a2 ccrA2 TAAAGGCATCAATGCACAAACACT FPR3757 (IVa)
JCSC1978 (IVb)
MR108 (IVc)
47977
6799
13495
6904 (IVa)
6904 (IVb)
6905 (IVc)
From ccrB2 to 3′’-SCCmec (over-
lapping J1)c
Bc (all subtypes) ccrB2 ATTGCCTTGATAATAGCCITCT FPR3757 (IVa)
JCSC1978 (IVb)
MR108 (IVc)
JCSC4469 (IVd)
47041
7735
14431
11066
7122 (IVa)
5278 (IVb)
6171 (IVc)
8676 (IVd)
4a1 (IVa) J1 IVa TTTGAATGCCCTCCATGAATAAAAT FPR3757 (IVa) 54163 7122 (IVa)
4b3 (IVb) J1 IVb AACCAACAGTGGTTACAGCTT JCSC1978 (IVb) 2457 5278 (IVb)
4c4 (IVc) J1 IVc AGGAAATCGATGTCATTATAA MR108 (IVc) 8260 6171 (IVc)
4d4 (IVd) J1 IVd AATTCACCCGTACCTGAGAA JCSC4469 (IVd) 2390 8676 (IVd)
Internal region of mecAb,d
mecED2 mecA ACGTGGAGACGAGCACTAATAACCA FPR3757 41374 1516
mecER mecA TTTTGCCAACCTTTACCATCGATT FPR3757 39833 1516
mecID1 mecA AGACCGAAACAATGTGGAATTGG FPR3757 40669 …
mecIR1 mecA CCAATTCCACATTGTTTCGGTCT FPR3757 40647 …
From J1 to the 3′ chromosomal
flanking regiond
4a3c J1 IVa AGAAAAGATAGAAGTTCGAAAGA FPR3757 53706 …
SE130–360b SE0130 GATTGTTTTATTTAGCGGCGAGC ATCC 12228 126481 …
a The GenBank accession numbers of methicillin-resistant Staphylococcus aureus (MRSA) reference strains are CP000255 (USA300-FPR3757), AB063173
(JCSC1978), AB096217 (MR108), and AB097677 (JCSC4469). Only the junkyard region J1 of SCCmec IVd was sequenced in MRSA strain JCSC4469. The GenBank
accession number of methicillin-susceptible Staphylococcus epidermidis strain American Type Culture Collection 12228 is AE015929.
b Primers designed for the purpose of this study.
c Primers from reference 35.
d Additional primers for complete sequencing of SCCmec IVa. medID1 and medIR1 primers were only used for mecA sequencing. The length from J1 to the 3′
chromosonal flanking region is not available.
∼6.5-kb amplicons reflecting a J3 region similar in orientation
and size to those sequenced in MRSA USA300-FPR3757 (IVa)
and JCSC1978 (IVb) (6213 and 6830 bp, respectively). A ∼7-
kb J2 amplicon was obtained in each strain, with a correspond-
ing mec-ccr distance of 6904 bp in reference strains of MRSA
(Table 3). The 9 strains with SCCmec IVa harbored an upstream
J1 region of ∼7 kb, as in USA300-FPR3757 (7122 bp). This
region was ∼5.5 kb long in the strain with SCCmec IVb, similar
to JCSC1978 (5278 bp). Only J2 was amplified in S. pettenkoferi
strains (amplicons ∼7 kb).
Sequencing of SCCmec IVa. Three MRSE strains were ran-
domly selected for SCCmec IVa sequencing (Table 5 and Figure
2). Strain BCB-F1 was isolated in a 78-year-old woman ad-
mitted for hip fracture (EHCS; hospitalization within the pre-
vious year for acute renal failure), BCB-F57 in a 55-year-old
woman hospitalized for scheduled hand surgery (non-EHCS;
no relevant medical history), and BCB-F63 in a 83-year-old
man with shoulder dislocation (EHCS; resident of a rest home,
no previous hospitalization). Overall sequence identity with
SCCmec IVa from CA-MRSA strain USA300-FPR3757 was
Table 4. ccr-mec Allotype Combinations in 83 Carriage Strains of Methicillin-Re-
sistant Coagulase-Negative Staphylococci and Staphylococcal Cassette Chromosome
mec (SCCmec) Assignment According to Current Classification Used for Methicillin-
Resistant Staphylococcus aureus
ccr-mec Combination;
SCCmec type assignmenta
No. (%) of strains
Staphylococcus
species
(no. of isolates)Overall
Non-EHCS
patients
EHCS
patients
2A: type II 3 (3.6) 2 (3.9) 1 (3.1) S. epidermidis (3)
2B: type IV 18 (21.7) 9 (17.6) 9 (28.1)
Subtype IVa 9 3 6 S. epidermidis (9)
Subtype IVb 1 1 0 S. epidermidis (1)
Subtype IVc 1 0 1 S. pettenkoferi (1)
Subtype IVd 1 0 1 S. pettenkoferi (1)
IVnst 6 5 1 S. epidermidis (6)
5 C2; type V 5 (6.0) 3 (5.9) 2 (6.2) S. haemolyticus
(5)
4 A; type VIII 7 (8.4) 4 (7.8) 3 (9.4) S. epidermidis (4),
S. hominis (3)
Nontypeable 50 (60.2) 33 (64.7) 17 (53.1)
NT A 7 5 2 S. epidermidis (5),
S. hominis (2)
NT B 4 2 2 S. epidermidis (1),
S. haemolyticus
(3)
NT C2 1 1 0 S. epidermidis (1)
1 A 5 4 1 S. hominis (4), S.
pettenkoferi (1)
2 C2 4 1 3 S. epidermidis (4)
2 NT 1 0 1 S. epidermidis (1)
4 C2 1 1 0 S. epidermidis (1)
5 A 1 1 0 S. cohnhii (1)
1–2 B 2 1 1 S. epidermidis (2)
1–2 C2 1 0 1 S. hominis (1)
1–4 A 2 2 0 S. epidermidis (1),
S. hominis (1)
1–5 C2 1 1 0 S. haemolyticus
(1)
2–4 A 2 0 2 S. epidermidis (2)
2–4 B 4 4 0 S. epidermidis (4)
2–5 A 3 1 2 S. epidermidis (3)
2–5 B 2 0 2 S. epidermidis (2)
2–5 C2 5 5 0 S. epidermidis (4),
S. haemolyticus
(1)
4–5 C2 1 1 0 S. epidermidis (1)
2–4–5 A 3 3 0 S. epidermidis (3)
Total 83 51 32
NOTE. EHCS, exposed to health care system.
a ccr allotypes are classified as types 1–4 (ccrAB1 to ccrAB4) and 5 (ccrC); ccrAB2, ccrC, and ccrAB1
were more frequent in S. epidermidis (75% vs 16% of strains from other species; P! .001), S. hae-
molyticus (70.0% vs 20.0%; Pp .003), and S. hominis (54.5% vs 6.8%; P! .001) strains, respectively.
SCCmec types are as defined in reference 11. IVnst, nonsubtypeable SCCmec type IV; NT, nontypeable
mec-ccr allotype.
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Figure 1. Genetic relationship of multiple-locus variable-number tandem repeat analysis (MLVA) patterns for methicillin-resistant Staphylococcus epi-
dermidis (MRSE) strains, as implemented by the BioNumerics software (version 6.0; Applied Maths). SCCmec, staphylococcal cassette chromosome mec,
defined by the ccr-mec allotype combination according to the current classification used in methicillin-resistant Staphylococcus aureus [11]; NT, nontypeable
ccr-mec allotypes or SCCmec types. Strains are MRSE strains as isolated from subjects with (solid triangles) or without (open triangles) previous exposure
to the health care system, MLVA patterns are defined as the number of tandem repeats for each of the 5 Se loci (Se1-Se2-Se3-Se4-Se5) [34], and ccr
allotypes are classified as types 1–4 (ccrAB1–ccrAB4) and 5 (ccrC).
99.99% for MRSE strains BCB-57 and BCB-F63 and 96.63%
for MRSE strain BCB-F1.
BCB-F1 carried an SCCmec IVa sequence ∼22.7 kb long
sharing 100% nucleotidic homology for J1 and J2 regions to
its counterparts in USA300-FPR3757, for CDSs as for intergen-
ic sequences. These 2 cassettes differed only in 2 intergenic se-
quences of their J3 regions by (1) the insertion in BCB-F1 of
2 fragments of 578 bp (at nucleotide 1656) and 39 bp (at
nucleotide 3716) that were 100% homologous to the corre-
sponding region of SCCmec IVa in CA-MRSA strain USA400-
MW2 (GenBank BA000033, nucleotides 35795–36372 and nu-
cleotides 37854–37893, respectively) and (2) the deletion in
Ta
bl
e
5.
CD
S
Li
st
s
of
St
ap
hy
lo
co
cc
al
Ca
ss
et
te
Ch
ro
m
os
om
e
m
ec
(S
CC
m
ec
)T
yp
e
IV
a
in
3
St
ra
in
s
of
M
et
hi
ci
lli
n-
Re
si
st
an
tS
ta
ph
yl
oc
oc
cu
s
ep
id
er
m
id
is
R
eg
io
n
R
ef
er
en
ce
St
ra
in
B
C
B
-F
1
St
ra
in
B
C
B
-F
57
St
ra
in
B
C
B
-F
63
C
D
S
(s
tr
ai
na
)
Le
ng
th
,
bp
Pr
ot
ei
n,
am
in
o
ac
id
s
Fu
nc
tio
n
C
D
S
St
ar
t,
nu
cl
eo
tid
e
Se
qu
en
ce
id
en
tit
y,
%
C
D
S
St
ar
t,
nu
cl
eo
tid
es
Se
qu
en
ce
id
en
tit
y,
%
C
D
S
St
ar
t,
nu
cl
eo
tid
e
Se
qu
en
ce
id
en
tit
y,
%
C
hr
om
os
om
eb
or
fX
–p
ar
tia
l(
AT
C
C
12
22
8)
30
N
A
…
F1
–0
1
1
10
0
F5
7–
01
1
95
F6
3–
01
1
10
0
SC
C
m
ec
J3
SA
U
SA
30
0_
02
7
(F
PR
37
57
)
12
57
41
8
C
H
P
F1
–0
2
35
2
10
0
F5
7–
02
35
1
10
0
F6
3–
02
35
2
10
0
SA
U
SA
30
0_
02
8
(F
PR
37
57
)
67
5
22
4
Tr
an
sp
os
as
ec
F1
–0
3
22
94
10
0
F5
7–
03
17
15
99
F6
3–
03
17
16
10
0
SA
U
SA
30
0_
02
9
(F
PR
37
57
)
16
8
55
C
H
P
F1
–0
4
32
26
10
0
F5
7–
04
26
47
10
0
F6
3–
04
26
48
10
0
SA
U
SA
30
0_
03
0
(F
PR
37
57
)
74
4
24
7
G
D
Pc
F1
–0
5
41
50
10
0
F5
7–
05
36
51
10
0
F6
3–
05
36
52
10
0
SA
U
SA
30
0_
03
1
(F
PR
37
57
)
42
9
14
2
C
H
P
F1
–0
6
49
90
10
0
F5
7–
06
44
91
10
0
F6
3–
06
44
92
10
0
m
ec
ge
ne
co
m
pl
ex
m
ec
A
(F
PR
37
57
)
20
07
66
8
PB
P2
a
F1
–0
7
54
64
10
0
F5
7–
07
49
65
10
0
F6
3–
07
49
66
10
0
m
ec
R
1
(F
PR
37
57
)
98
7
32
8
m
ec
A
re
gu
la
to
r
F1
–0
8
75
70
10
0
F5
7–
08
70
71
10
0
F6
3–
08
70
72
10
0
SC
C
m
ec
J2
SA
U
SA
30
0_
03
5
(F
PR
37
57
)
21
6
71
C
H
P
F1
–0
9
85
73
10
0
F5
7–
09
80
74
10
0
F6
3–
09
80
75
10
0
IS
12
72
(F
PR
37
57
)
15
12
50
3
Tr
an
sp
os
as
e
F1
–1
0
87
79
10
0
F5
7–
10
82
80
99
F6
3–
10
82
81
10
0
SA
U
SA
30
0_
03
6
(F
PR
37
57
)
50
7
16
8
C
H
P
F1
–1
1
10
43
8
10
0
F5
7–
11
99
39
10
0
F6
3–
11
99
40
10
0
cc
r
ge
ne
co
m
pl
ex
cc
rB
2
(F
PR
37
57
)
16
29
54
2
R
ec
om
bi
na
se
s
F1
–1
2
12
22
9
10
0
F5
7–
12
11
73
0
10
0
F6
3–
12
11
73
1
10
0
cc
rA
2
(F
PR
37
57
)
13
50
44
9
A
2/
B
2
F1
–1
3
13
87
9
10
0
F5
7–
13
13
38
0
10
0
F6
3–
13
13
38
1
10
0
SC
C
m
ec
J1
SA
U
SA
30
0_
03
9
(F
PR
37
57
)
17
88
59
5
C
H
P
F1
–1
4
15
46
2
10
0
F5
7–
14
14
96
3
10
0
F6
3–
14
14
96
4
10
0
SA
U
SA
30
0_
04
0
(F
PR
37
57
)
29
1
96
C
H
P
F1
–1
5
17
24
9
10
0
F5
7–
15
16
75
0
10
0
F6
3–
15
16
75
1
10
0
SA
U
SA
30
0_
04
1
(F
PR
37
57
)
10
92
36
3
C
H
P
F1
–1
6
17
63
6
10
0
F5
7–
16
17
13
7
10
0
F6
3–
16
17
13
8
10
0
SA
U
SA
30
0_
04
2
(F
PR
37
57
)
14
91
49
6
C
H
P
F1
–1
7
19
45
5
10
0
F5
7–
17
18
95
6
99
F6
3–
17
18
95
7
10
0
SA
U
SA
30
0_
04
3
(F
PR
37
57
)
17
4
57
C
H
P
F1
–1
8
21
31
8
10
0
F5
7–
18
20
81
9
10
0
F6
3–
18
20
82
0
10
0
SA
U
SA
30
0_
04
4
(F
PR
37
57
)
10
05
33
4
C
H
P
F1
–1
9
21
56
9
99
F5
7–
19
21
06
9d
10
0
F6
3–
19
21
07
1
99
C
hr
om
os
om
eb
SE
01
30
-p
ar
tia
l(
AT
C
C
12
22
8)
25
0
N
A
…
F1
–2
0
22
67
0
99
…
…
…
F6
3–
20
22
17
2
99
N
O
TE
.
C
D
S,
co
di
ng
se
qu
en
ce
;C
H
P,
co
ns
er
ve
d
hy
po
th
et
ic
al
pr
ot
ei
n;
G
D
P,
gl
yc
er
op
ho
sp
ho
ry
ld
ie
st
er
ph
os
ph
od
ie
st
er
as
e;
J,
ju
nk
ya
rd
re
gi
on
;N
A
,n
ot
ap
pl
ic
ab
le
;P
B
P2
a,
pe
ni
ci
lli
n-
bi
nd
in
g
pr
ot
ei
n
2A
.
a
Th
e
G
en
B
an
k
ac
ce
ss
io
n
nu
m
be
rs
ar
e
A
E0
15
92
9
fo
r
m
et
hi
ci
lli
n-
su
sc
ep
tib
le
S.
ep
id
er
m
id
is
st
ra
in
AT
C
C
12
22
8
an
d
C
P0
00
25
5
fo
r
m
et
hi
ci
lli
n-
re
si
st
an
t
St
ap
hy
lo
co
cc
us
au
re
us
st
ra
in
U
SA
30
0-
FP
R
37
57
.
b
O
nl
y
th
e
3′
en
d
of
or
fX
(to
ta
ll
en
gt
h,
48
0
bp
)a
nd
th
e
5’
en
d
of
SE
01
30
(to
ta
ll
en
gt
h,
81
6
bp
)w
er
e
se
qu
en
ce
d
in
th
e
3
S.
ep
id
er
m
id
is
st
ra
in
s.
c
Pu
ta
tiv
e
fu
nc
tio
n.
d
Pa
rt
ia
l(
se
qu
en
ce
le
ng
th
,3
22
bp
).
278 • JID 2010:202 (15 July) • Barbier et al
Figure 2. Structure and chromosomal coding sequence (CDS) content of staphylococcal cassette chromosome mec (SCCmec) IVa in methicillin-resistant
Staphylococcus epidermidis (MRSE) strains BCB-F1, BCB-F57, and BCB-F63 and community-acquired methicillin-resistant Staphylococcus aureus (CA-MRSA)
strain USA300-FPR3757. CDSs located within SCCmec are indicated in black, and chromosomal CDSs in gray; GenBank accession numbers are provided
in brackets. The first 30 nucleotides in MRSE strains correspond to the 3’ end of orfX. All of the CDSs located on SCCmec IVa in MRSE strains displayed
199% nucleotidic homology relative to their counterparts in USA300-FPR3757. aFindings as annotated by Diep et al [15]. The type I arginine catabolic
mobile element (ACME) located downstream of SCCmec in USA300-FPR3757 (nucleotides 57914–88899) is not represented here. bSE0130 is the chromosomal
CDS located immediately downstream of orfX in methicillin-susceptible S. epidermidis strain American Type Culture Collection 12228 (GenBank accession
no. AE015929). The junction between J1 and SE0130 was not amplifiable in the ACME-copA–positive strain BCB-F57 (see text for details). cTwo fragments
of 578 bp (at nucleotide 1656) and 39 bp (at nucleotide 3716) were inserted in the J3 region of SCCmec IVa in strain BCB-F1 and were 100% homologous
to the corresponding region of SCCmec IVa in CA-MRSA strain USA400-MW2 (GenBank accession no. BA000033, nucleotides 35795–36372 and nucleotides
37854–37893, respectively).
BCB-F1 of 2 fragments of 79 bp (at nucleotide 3821) and 39
bp (at nucleotide 3991), with 12-point mutations between these
2 locations. The remaining intergenic sequences and all of the
CDSs located on J3 in BCB-F1 displayed 199% and 100%
homology, respectively, with their counterparts in USA300-
FPR3757. MRSE strain BCB-F63 carried an SCCmec IVa se-
quence ∼22.1 kb long that was 100% and 199% homologous
to that sequenced in USA300-FPR3757 for CDSs and intergenic
sequences, respectively.
CDSs F1–20 and F63–20 were 199% homologous to the
SE0130 locus of MSSE strain ATCC 12228, which confirmed
the connection between the 3′ boundaries of SCCmec and the
right-flanking chromosomal regions of strains BCB-F1 and
BCB-F63.
An ∼21.1-kb-long sequence of SCCmec IVa was obtained in
BCB-F57, with 14 and 3 CDSs displaying 100% and 199%
homology with their counterparts in USA300-FPR3757, re-
spectively. The 3′ SCCmec-chromosome junction could not be
amplified by LR-PCR in this strain, which suggested the in-
sertion in orfX of another mobile genetic element downstream
of SCCmec IVa. Three markers of ACME, namely, arcA,
opp3AB, and copA, were screened by PCR, using USA300-
FPR3757 as a positive control [41]. Only copA was amplified.
An additional LR-PCR assay indicated that copA was located
∼4 kb upstream of SE0130 in BCB-F57.
These 3 SCCmec IVa sequences displayed 199.9% sequence
identity with their counterparts in other reference strains of
CA-MRSA (ie, USA400-MW2 and CA05-JCSC1968), except for
2 intergenic sequences of J3, as described for strain BCB-F1
(data not shown).
GenBank accession numbers. Sequences of SCCmec IVa
with surrounding partial sequences of orfX (for the 3 strains)
and SE0130 (for BCB-F1 and BCB-F63) are available at http://
www.ncbi.nlm.nih.gov/GenBank under numbers GU451305
(BCB-F1), GU451306 (BCB-F57), and GU451307 (BCB-F63).
DISCUSSION
In this study, carriage of MRSE-SCCmec type IV was found to
be common in patients at hospital admission, including those
with no previous exposure to the health care system, with an
overall colonization rate of 5.2%. LR-PCR assays confirmed
that structures of these SCCmec IV were similar to those de-
scribed in MRSA. Moreover, we provide complete sequences
of SCCmec IVa from MRSE strains circulating in the com-
munity, with a high homology to sequences of SCCmec IVa
carried by major CA-MRSA clones USA300 and USA400.
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Worldwide emergence of numerous unrelated CA-MRSA
clones has been one of the most alarming phenomena in terms
of antibiotic resistance over the past decade. Most of these
clones carry SCCmec IVa [7, 15, 16, 19]. The small size of this
SCCmec variant may enhance its mobility and ease its current
spread among MRSA in the community, as in the hospital [17,
18], with a possible impact of frequent vancomycin use in the
latter setting [42]. Several reports suggest that new HCA-MRSA
strains can arise as a result of SCCmec transfer between MR-
CoNS and MSSA [22, 26–28]. It could be hypothesized that
some CA-MRSA clones have emerged from a similar, com-
munity-based event. As recently reported in Japan [25], we
observed that SCCmec IVa was disseminated among carriage
strains of MRSE. Moreover, cocolonization by MSSA and
MRSE-SCCmec IVa was found to be possible in patients at
hospital admission. In this context, community diffusion and
silent in-hospital influx of MRSE-SCCmec IV may reflect a
widely accessible reservoir of methicillin resistance for S. aureus
in these 2 environments.
Very few SCCmec elements have been fully sequenced in
MRSE [29, 39]. One study reported 198% nucleotide identity
for SCCmec IVa between MRSA strain CA05-JCSC1968 and
clinical MRSE strains causing prosthetic valve endocarditis, a
mainly health care–associated infection. SCCmec sequences
from these MRSE strains are not available for comparison in
the GenBank database [29]. In our study, sequencing of
SCCmec IVa in 3 MRSE strains (including 2 from patients with
no previous hospitalization) provided further arguments for
SCCmec exchange between S. aureus and S. epidermidis. Strain
BCB-F63 harbored SCCmec IVa with 99.99% nucleotide iden-
tity compared with the cassette sequenced in USA300-FPR3757
[15]. A similar observation was made in strain BCB-F1, except
for the 5’-end of the J3 region, which may result from recom-
bination with another SCCmec IVa element identical to that
sequenced in USA400-MW2 [15, 16]. Finally, strain BCB-F57
carried SCCmec IVa that was 99.99% identical to its counter-
part in USA300-FPR3757, with the likely insertion of another
mobile genetic element between the 3′ end of SCCmec and the
right-flanking chromosomal locus (SE0130).
Interestingly, this additional region contained copA, an
ACME-associated gene located immediately upstream of the
right chromosomal junction of the SCCmec IVa-ACME type I
composite element in USA300-FPR3757 and of ACME type II
in MSSE strain ATCC 12228 [15, 24]. However, BCB-F57 did
not carry the arc operon integrated in ACME types I and II
nor the opp3 operon, which was described only in ACME type
I. Spontaneous, subtotal deletion of an ACME located down-
stream of SCCmec IVa might have occurred in BCB-F57 or its
precursor. A degree of homologous recombination between dis-
tinct SCC elements is another eventuality, as recently suggest-
ed for SCCmec VIII in MRSA strain C10682 [9]. Nevertheless,
these data constitute one more line of evidence supporting the
role of MRSE as a pool of SCCmec IVa for S. aureus.
As we studied MRSE strains probably circulating in French
community settings and hospitals, comparison with complete
sequences of SCCmec IVa from the leading European CA-
MRSA clone ST80 would have been of major interest to further
assess this hypothesis. Unfortunately, these sequences are not
yet deposited in GenBank. Only a partial, conserved ccrA2 se-
quence from ST80 is currently available (GenBank accession
number AY669512) [43], and it is 100% homologous to those
obtained in our 3 strains.
The overall biodiversity of MR-CoNS colonizing community
subjects has been scarcely assessed [21, 25, 44]. We confirm
here the extreme structural heterogeneity of SCCmec elements
among CA-MR-CoNS strains, with two-thirds of them carrying
untypeable ccr-mec combinations. No significant difference was
found in this respect with strains from EHCS subjects. This
high polymorphism in community-acquired strains, notably in
CA-MRSE, suggests that rearrangements and horizontal trans-
fers of this resistance island frequently occur despite a relatively
low antibiotic exposure. Data from MLVA support this evi-
dence, as nearly all MRSE strains harbored a distinct genetic
background, whether they carried a type IV or another SCCmec
element. Similar findings were recently reported in CA-MRSE
strains from Japan [25]. This observation contrasts with results
of SCCmec typing in S. aureus, with most CA-MRSA strains
carrying well-defined SCCmec patterns, such as types IV and
V. Genomic plasticity in CoNS species, as suggested for S. ep-
idermidis [24, 39] and S. haemolyticus [23], may ease sequential
insertions of foreign genetic elements in orfX and contribute
to the frequent generation of new SCC elements.
Regardless of SCCmec typing, we found that almost 20% of
patients were MR-CoNS carriers at hospital admission, with a
trend toward a higher prevalence in EHCS subjects. Hospital-
ization in the previous year, long-term hemodialysis, nursing
care at home, and living in a rest home increase the risk of
HCA-MRSA nasal carriage [45]. Our data suggest that similar
risk factors exist for MR-CoNS colonization, in agreement with
the demonstrated impact of antibiotic pressure and cross-trans-
mission on this carriage in hospitalized patients [46]. More
strikingly, 16.5% of non-EHCS subjects carried MR-CoNS, with
high rates of non–b-lactam coresistances. The diffusion of MR-
CoNS in individuals with no underlying risk factor has been
recently reported in non-European populations [21, 25, 44].
This spread may elicit additional concerns, given that CoNS
are increasingly reported in community-acquired diseases, such
as native-valve endocarditis and late-onset infections of pros-
thetic heart valves, pacemakers, and orthopedic prostheses [47–
49].
Our work has some limitations that should be mentioned.
First, patients were classified as EHCS or non-EHCS on the
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basis of a questionnaire including items on hospitalization
within the previous year, home nursing care, long-term he-
modialysis, life in a nursing home, and health care jobs. We
cannot exclude the possibility that some non-EHCS patients
had experienced earlier hospitalization (11 year) or emergency
department visits without hospital admission, and the impact
of such exposure on MR-CoNS carriage is currently unknown.
Next, nasal samples were obtained in the orthopedic ward, not
in the emergency department. However, isolation at ward ad-
mission of a MR-CoNS strain acquired during emergency de-
partment transit is unlikely, because emergency department
stays in our hospital are usually !6 h as a result of prompt
ward transfer policy. Finally, reliable retrospective data on an-
tibiotic use during the months before inclusion were unavail-
able, notably for non-EHCS subjects. Consequently, we could
not confirm that antibiotic exposure increases the MR-CoNS
carriage rate in these patients, as suggested elsewhere [50].
In conclusion, this study provides new data concerning the
role of MR-CoNS as a wide and evolutionary pool of SCCmec
in the community, as in hospitalized patients. Most notably,
our results argue for exchanges of SCCmec IVa between S.
epidermidis and S. aureus, a worrisome report for western Eu-
ropean countries, where incidence of CA-MRSA remains still
relatively low [51].
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